Example: Heart Attack

Clinical Trials on Uterine Sarcoma

Total 124 results

NCT00162721

Unknown status

The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas

Conditions: Uterine Sarcoma
NCT03493165

Available

Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

Conditions: Uterine Sarcoma
NCT01979393

Recruiting

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

Conditions: Uterine Sarcoma
NCT04250766

Not yet recruiting

Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)

Conditions: Fibroid Uterus; Sarcoma Uterus
NCT03509207

Terminated

Vorinostat (SAHA) in Uterine Sarcoma

Conditions: Leiomyosarcoma; Endometrial Stromal Tumors; Carcinosarcomas Uterine
NCT01303094

Completed

Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma; Uterine Sarcoma
NCT01061606

Terminated

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Conditions: Recurrent Uterine Sarcoma; Uterine Carcinosarcoma
NCT04123158

Recruiting

MYometrial Lesion UltrasouNd And mRi

Conditions: Sarcoma Uterus
NCT00378911

Completed

Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Conditions: Recurrent Uterine Sarcoma; Uterine Leiomyosarcoma
NCT00075400

Completed

Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Sarcoma; Uterine Carcinosarcoma
NCT01958580

Terminated

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Conditions: Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine Corpus Leiomyosarcoma
NCT00002706

Completed

Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus

Conditions: Endometrial Adenocarcinoma; Stage I Uterine Corpus Cancer; Stage I Uterine Sarcoma; Stage II Uterine Corpus Cancer; Stage II Uterine Sarcoma
NCT01533207

Terminated

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Conditions: Stage I Uterine Sarcoma AJCC v7; Uterine Corpus Leiomyosarcoma
NCT00002993

Terminated

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Conditions: Sarcoma
NCT01637961

Completed

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
NCT00238121

Completed

Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

Conditions: Recurrent Uterine Sarcoma; Stage III Uterine Sarcoma; Stage IV Uterine Sarcoma; Uterine Carcinosarcoma
NCT01247571

Completed

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT01168232

Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT01220609

Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
NCT00114218

Completed

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT00025506

Completed

Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
NCT00025220

Completed

Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
NCT00031629

Completed

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Conditions: Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
NCT00002459

Completed

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Conditions: Endometrial Cancer; Sarcoma
NCT00005643

Completed

Chemotherapy in Treating Patients With Sarcoma of the Uterus

Conditions: Endometrial Cancer; Sarcoma